# Sun Pharmaceutical Industries Ltd has announced a landmark acquisition of Organon & Co, a US-based company, for a whopping USD 11.75 billion.

*biotech · news · 2026-04-27 · Devdiscourse*

## Key points

- Sun Pharmaceutical will acquire US-based Organon & Co for USD 11.75 billion.
- This is the largest-ever overseas acquisition by an Indian pharmaceutical company.
- The deal is India's second-largest outbound transaction after Tata Steel's Corus acquisition.
- Sun Pharma's acquisition of Organon will strengthen India's position in the global pharmaceutical market.

**Companies:** Sun Pharmaceutical Industries Ltd, Organon & Co
**Countries:** India, United States

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/business/3888381-indian-giants-making-big-moves-sun-pharmas-landmark-acquisition)

---

Canonical: https://newsio.io/n/f12d4a9c-ac65-4a17-b8a8-bd2e93a8f9e5/sun-pharmaceutical-industries-ltd-has-announced-a-landmark-acquisition-of-organo
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works